CDC Reports Surge in Antibiotic-Resistant Stomach Bug
Credit: TribLIVE.com
Women's Health

CDC Reports Surge in Antibiotic-Resistant Stomach Bug

The CDC reports a surge in antibiotic-resistant stomach bug, specifically shigellosis, with extensively drug-resistant cases reaching 9% in 2023. This common stomach bug is becoming harder to treat, joining the growing list of infections that can withstand multiple antibiotics.

CDC Warns of Rising Drug-Resistant Stomach Bug

The Centers for Disease Control and Prevention (CDC) reports a surge in antibiotic-resistant stomach bug cases across the United States. According to the agency, a common stomach bug is becoming harder to treat, as it now joins the growing list of infections that can withstand several lines of antibiotics. This development raises concerns among public health officials about the effectiveness of current treatments.

A CDC report released this month found that “extensively drug-resistant” bacteria caused about 9% of shigellosis cases in 2023. The percentage of extensively drug-resistant shigellosis cases in 2023 was up compared to previous years, indicating a troubling trend. Shigellosis, caused by Shigella bacteria, typically leads to diarrhea, fever, and stomach cramps, and is often spread through contaminated food or water.

Extensively Drug-Resistant Cases on the Rise

The CDC’s findings highlight a significant increase in the proportion of shigellosis cases that are resistant to multiple antibiotics. In 2023, approximately 9% of infections were classified as extensively drug-resistant, meaning they do not respond to most commonly used antibiotics. This marks a sharp rise from earlier years, though the source did not provide specific comparative figures.

This surge is part of a broader pattern of antimicrobial resistance, which the World Health Organization has identified as one of the top global public health threats. The CDC emphasizes that the stomach bug is now among a growing list of infections that can withstand several lines of antibiotics, complicating treatment and increasing the risk of severe outcomes.

Implications for Public Health

The rise of extensively drug-resistant shigellosis poses challenges for healthcare providers, who may need to rely on last-resort antibiotics or alternative therapies. The CDC advises that patients with symptoms of shigellosis should consult a healthcare professional for proper diagnosis and treatment. Self-medication with antibiotics is strongly discouraged, as it can contribute to further resistance.

Public health officials are urging vigilance in hygiene practices, such as frequent handwashing and safe food handling, to prevent the spread of Shigella. The CDC continues to monitor resistance patterns and update treatment guidelines accordingly. As the situation evolves, staying informed and following medical advice remains crucial.

Frequently Asked Questions

What percentage of shigellosis cases in 2023 were caused by extensively drug-resistant bacteria according to the CDC?

According to a CDC report released this month, extensively drug-resistant bacteria caused about 9% of shigellosis cases in 2023, up from previous years.

Why is the CDC concerned about the stomach bug Shigella?

The CDC reports that Shigella, a common stomach bug, is becoming harder to treat because it has developed resistance to several lines of antibiotics, making it extensively drug-resistant.

What did the CDC add to the growing list of antibiotic-resistant infections?

The CDC added the stomach bug Shigella to the growing list of infections that can withstand several lines of antibiotics, as reported in their recent report.

Source

About the author

Natural Medical Post Editorial TeamHealth & Wellness Research Team

Our editorial team reviews health and wellness topics based on peer-reviewed research and trusted medical sources.